Suvretta Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-268,100
| Closed | -$4.83M | – | 112 |
|
|
2024
Q3 | $4.83M | Hold |
268,100
| – | – | 0.15% | 61 |
|
|
2024
Q2 | $4.36M | Hold |
268,100
| – | – | 0.16% | 54 |
|
|
2024
Q1 | $3.78M | Sell |
268,100
-229,300
| -46% | -$3.24M | 0.14% | 65 |
|
|
2023
Q4 | $5.19M | Hold |
497,400
| – | – | 0.23% | 52 |
|
|
2023
Q3 | $5.07M | Buy |
+497,400
| New | +$5.07M | 0.27% | 52 |
|
|
2016
Q1 | – | Sell |
-1,426,800
| Closed | -$93.7M | – | 25 |
|
|
2015
Q4 | $93.7M | Buy |
+1,426,800
| New | +$93.7M | 4.61% | 10 |
|
|
2015
Q2 | – | Sell |
-406,201
| Closed | -$25.3M | – | 36 |
|
|
2015
Q1 | $25.3M | Buy |
+406,201
| New | +$25.3M | 1.51% | 23 |
|
|
2014
Q2 | – | Sell |
-213,800
| Closed | -$11.3M | – | 42 |
|
|
2014
Q1 | $11.3M | Buy |
+213,800
| New | +$11.3M | 1.34% | 27 |
|